Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Submits New Drug Application for IV Meloxicam 30mg

MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
July 21, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Inducement Grants for New Staff

MALVERN, Pa., July 21, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
July 10, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Inducement Grants for New Staff

MALVERN, Pa., July 10, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
July 05, 2017 08:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Acquires Novel Neuromuscular Blocking Agents

MALVERN, Pa., July 05, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
June 26, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Added to the Russell 3000® Index

MALVERN, Pa., June 26, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
June 16, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Participate in Hospital Drug Launch Panel at the JMP Life Sciences Conference

MALVERN, Pa., June 16, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
June 15, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Inducement Grants for New Staff

MALVERN, Pa., June 15, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
June 06, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Appoints Ryan D. Lake as Senior Vice President of Finance and Chief Accounting Officer

MALVERN, Pa., June 06, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
June 02, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Participate in Upcoming Investor Conferences

MALVERN, Pa., June 02, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
May 18, 2017 08:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Presents Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting

MALVERN, Pa., May 18, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...